These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37373188)

  • 1. STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (
    Lin Z; Liu Y; Xu T; Su T; Yang Y; Liang R; Gu S; Li J; Song X; Liang B; Leng Z; Li Y; Meng L; Luo Y; Chang X; Huang D; Xie L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.
    Meng J; Liu K; Shao Y; Feng X; Ji Z; Chang B; Wang Y; Xu L; Yang G
    Cell Death Dis; 2020 Feb; 11(2):137. PubMed ID: 32080166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of DNA-binding protein 1 knockdown arrests the growth of colorectal cancer cells and suppresses hepatic metastasis in vivo.
    Lai X; Liao J; Lin W; Huang C; Li J; Lin J; Chen Q; Ye Y
    Oncol Rep; 2014 Jul; 32(1):79-88. PubMed ID: 24804700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
    Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
    Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
    Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
    Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis.
    Niu B; Liu J; Lv B; Lin J; Li X; Wu C; Jiang X; Zeng Z; Zhang XK; Zhou H
    Nat Commun; 2021 May; 12(1):2809. PubMed ID: 33990575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GCIP functions as a tumor suppressor in non-small cell lung cancer by suppressing Id1-mediated tumor promotion.
    Chen KY; Chen CC; Tseng YL; Chang YC; Chang MC
    Oncotarget; 2014 Jul; 5(13):5017-28. PubMed ID: 24970809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 11. ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1.
    Jin J; Wang H; Si J; Ni R; Liu Y; Wang J
    Clin Sci (Lond); 2019 Jan; 133(2):381-392. PubMed ID: 30626729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Id1 reduces proliferation and invasion in aggressive human salivary gland cancer cells.
    Sumida T; Murase R; Onishi-Ishikawa A; McAllister SD; Hamakawa H; Desprez PY
    BMC Cancer; 2013 Mar; 13():141. PubMed ID: 23517130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
    Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
    J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.
    Corvinus FM; Orth C; Moriggl R; Tsareva SA; Wagner S; Pfitzner EB; Baus D; Kaufmann R; Huber LA; Zatloukal K; Beug H; Ohlschläger P; Schütz A; Halbhuber KJ; Friedrich K
    Neoplasia; 2005 Jun; 7(6):545-55. PubMed ID: 16036105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MAPKAPK5-AS1 promotes colorectal cancer progression by cis-regulating the nearby gene MK5 and acting as a let-7f-1-3p sponge.
    Yang T; Chen WC; Shi PC; Liu MR; Jiang T; Song H; Wang JQ; Fan RZ; Pei DS; Song J
    J Exp Clin Cancer Res; 2020 Jul; 39(1):139. PubMed ID: 32690100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner.
    Nair S; Bora-Singhal N; Perumal D; Chellappan S
    Mol Cancer; 2014 Jul; 13():173. PubMed ID: 25028095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) modulates inhibitor of DNA binding 1 (ID1) to facilitate papillary thyroid carcinoma development by sponging microRNA-524-5p.
    Liao G; Huang Z; Gan T; Wu C; Wang X; Li D
    Bioengineered; 2022 May; 13(5):13201-13212. PubMed ID: 35635748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG acts as a STAT3 target gene for colorectal cancer cell growth and motility.
    Zhou C; Tong Y; Wawrowsky K; Melmed S
    Oncogene; 2014 Feb; 33(7):851-61. PubMed ID: 23416975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ_0000372 contributes to the proliferation, migration and invasion of colorectal cancer by elevating IL6 expression via sponging miR-495.
    Liu X; Qin Y; Tang X; Wang Y; Bian C; Zhong J
    Anticancer Drugs; 2021 Mar; 32(3):296-305. PubMed ID: 33534412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
    Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
    Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.